Market Closed -
Nasdaq
04:30:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.845
USD
|
+1.68%
|
|
+1.81%
|
-24.55%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
507.7
|
59.28
|
80.19
|
60.85
|
-
|
-
|
Enterprise Value (EV)
1 |
507.7
|
59.28
|
80.19
|
60.85
|
60.85
|
60.85
|
P/E ratio
|
-0.41
x
|
-0.81
x
|
-1.81
x
|
-1.63
x
|
-1.69
x
|
-1.92
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
8.7
x
|
7.27
x
|
4.76
x
|
3.76
x
|
3.09
x
|
EV / Revenue
|
-
|
8.7
x
|
7.27
x
|
4.76
x
|
3.76
x
|
3.09
x
|
EV / EBITDA
|
-
|
-0.95
x
|
-1.89
x
|
-1.5
x
|
-
|
-
|
EV / FCF
|
-
|
-
|
-1.88
x
|
-1.41
x
|
-1.58
x
|
-
|
FCF Yield
|
-
|
-
|
-53.1%
|
-70.8%
|
-63.4%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
70,032
|
70,576
|
71,600
|
72,008
|
-
|
-
|
Reference price
2 |
7.250
|
0.8400
|
1.120
|
0.8450
|
0.8450
|
0.8450
|
Announcement Date
|
3/23/22
|
3/21/23
|
3/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
6.814
|
11.03
|
12.79
|
16.19
|
19.7
|
EBITDA
1 |
-
|
-62.21
|
-42.32
|
-40.65
|
-
|
-
|
EBIT
1 |
-
|
-73.87
|
-48.12
|
-40.91
|
-37.62
|
-33.82
|
Operating Margin
|
-
|
-1,084.15%
|
-436.14%
|
-319.97%
|
-232.4%
|
-171.66%
|
Earnings before Tax (EBT)
1 |
-
|
-73.16
|
-44.24
|
-37.35
|
-35.78
|
-31.98
|
Net income
1 |
-64.85
|
-73.16
|
-44.24
|
-37.35
|
-35.78
|
-31.98
|
Net margin
|
-
|
-1,073.73%
|
-401%
|
-292.1%
|
-221%
|
-162.29%
|
EPS
2 |
-17.57
|
-1.040
|
-0.6200
|
-0.5200
|
-0.5000
|
-0.4400
|
Free Cash Flow
1 |
-
|
-
|
-42.61
|
-43.05
|
-38.6
|
-
|
FCF margin
|
-
|
-
|
-386.27%
|
-336.68%
|
-238.42%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/23/22
|
3/21/23
|
3/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
1.509
|
1.533
|
2.348
|
1.424
|
2.635
|
3.381
|
2.33
|
2.686
|
3.053
|
3.097
|
3.19
|
3.413
|
EBITDA
1 |
-
|
-
|
-
|
-13.04
|
-11.58
|
-11.66
|
-10.3
|
-11.5
|
-10.08
|
-10.54
|
-10.08
|
-9.6
|
-9.62
|
EBIT
1 |
-
|
-23.77
|
-23.19
|
-13.28
|
-13.63
|
-13.04
|
-11.69
|
-11.76
|
-11.63
|
-10.83
|
-10.37
|
-9.9
|
-9.95
|
Operating Margin
|
-
|
-1,575.28%
|
-1,512.85%
|
-565.67%
|
-957.09%
|
-494.69%
|
-345.81%
|
-504.68%
|
-432.95%
|
-354.69%
|
-334.88%
|
-310.34%
|
-291.5%
|
Earnings before Tax (EBT)
1 |
-
|
-23.78
|
-23.16
|
-13.17
|
-13.06
|
-12.16
|
-10.64
|
-10.76
|
-10.68
|
-9.91
|
-9.45
|
-8.97
|
-9.02
|
Net income
1 |
-16.39
|
-23.78
|
-23.16
|
-13.17
|
-13.06
|
-12.16
|
-10.64
|
-10.76
|
-10.68
|
-9.91
|
-9.45
|
-8.97
|
-9.02
|
Net margin
|
-
|
-1,575.55%
|
-1,510.7%
|
-560.95%
|
-917.06%
|
-461.48%
|
-314.61%
|
-461.67%
|
-397.77%
|
-324.56%
|
-305.17%
|
-281.19%
|
-264.26%
|
EPS
2 |
-2.890
|
-0.3400
|
-0.3300
|
-0.1900
|
-0.1900
|
-0.1700
|
-0.1500
|
-0.1500
|
-0.1500
|
-0.1467
|
-0.1333
|
-0.1333
|
-0.1267
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/26/21
|
5/11/22
|
8/10/22
|
11/10/22
|
3/21/23
|
5/11/23
|
8/14/23
|
11/9/23
|
3/22/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-42.6
|
-43.1
|
-38.6
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
0.8
|
3.8
|
5.1
|
-
|
Capex / Sales
|
-
|
-
|
7.29%
|
29.72%
|
31.5%
|
-
|
Announcement Date
|
3/23/22
|
3/21/23
|
3/22/24
|
-
|
-
|
-
|
Last Close Price
0.845
USD Average target price
1.3
USD Spread / Average Target +53.85% Consensus |
1st Jan change
|
Capi.
|
---|
| -24.55% | 60.85M | | -5.77% | 14.68B | | -40.71% | 2.71B | | -12.92% | 2.44B | | -8.78% | 1.51B | | -.--% | 1.12B | | +40.66% | 518M | | +91.79% | 502M | | +11.68% | 239M | | +1.67% | 183M |
Medical Imaging Systems
|